Milestone Pharmaceuticals (MIST) Work In Process (2025 - 2026)

Milestone Pharmaceuticals' (MIST) quarterly Work In Process came in at $1.6 million in Q1 2026, up 209.6% on a QoQ basis from $521000.0 in Q4 2025.

Milestone Pharmaceuticals (MIST) Work In Process (2025 - 2026) Analysis & Trends

Milestone Pharmaceuticals (MIST) has 2 years of Work In Process data on file, last reported at $1.6 million in Q1 2026.

Quarterly Work In Process changed N/A year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (changed N/A YoY) and the FY2025 annual result came in at $521000.0, changed N/A from the prior year.
Work In Process improved to $1.6 million in Q1 2026, from $521000.0 in the prior quarter.
In the past five years, Work In Process ranged from a high of $1.6 million in Q1 2026 to a low of $521000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.75 Bn	130.90 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.96 Bn	77.96 Bn	3.93 Bn
3	Argenx Se	64.98 Bn	59.80 Bn	1.37 Bn
4	Moderna	56.33 Bn	51.19 Bn	52.00 Mn
5	BeOne Medicines	42.03 Bn	36.93 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.56 Bn	28.25 Bn	992.69 Mn
7	BioNTech SE	27.74 Bn	9.35 Bn	668.28 Mn
8	Insmed	27.47 Bn	26.31 Bn	358.27 Mn
9	Royalty Pharma	27.32 Bn	26.49 Bn	-
10	Milestone Pharmaceuticals	43.11 Mn	-128.39 Mn	-

Download Data